Granulomatosis with polyangiitis provoked by trauma.
Royal Hallamshire Hospital, Sheffield, United Kingdom. Electronic address: s.j.carter@sheffield.ac.uk.
Stuart
S
Carter
Royal Hallamshire Hospital, Sheffield, United Kingdom.
Vipul
V
Ramjiani
Royal Hallamshire Hospital, Sheffield, United Kingdom.
Lisa
L
Dunkley
Royal Hallamshire Hospital, Sheffield, United Kingdom.
Sachin
S
Salvi
D000328:Adult; D015415:Biomarkers / Q000378:metabolism; D003520:Cyclophosphamide / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005131:Eye Injuries / Q000209:etiology*; D005938:Glucocorticoids / Q000627:therapeutic use; D014890:Granulomatosis with Polyangiitis / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000209:etiology*; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D015835:Ocular Motility Disorders / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000209:etiology*; D009801:Oculomotor Muscles / Q000473:pathology*; D009917:Orbital Fractures / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000209:etiology*; D000069283:Rituximab / Q000627:therapeutic use; D014057:Tomography, X-Ray Computed
D015415:Biomarkers; D005938:Glucocorticoids; D007155:Immunologic Factors; D007166:Immunosuppressive Agents; D000069283:Rituximab; D003520:Cyclophosphamide; D008775:Methylprednisolone